Thailand's Food and Drug Administration (FDA) has given approval for the Moderna Covid-19 vaccine to be administered to adolescents aged from 12 to 17, ZP Therapeutics, a division of Zuellig Pharma, announced on Thursday.
The company said the vaccination regimen is the same as that for adults -- two doses of the vaccine to be administered 28 days apart.
"The approval of Covid-19 vaccine Moderna for use in adolescents expands the vaccine arsenal that Thailand has to combat the pandemic. We are grateful that the FDA has authorised the use of the Moderna vaccine for adolescents so that they can be offered protection against the coronavirus, especially in light of the highly contagious Delta variant," the company said.